Sensile Medical is Being Acquired by Gerresheimer AG

Gerresheimer will acquire the Swiss technology company Sensile
Medical and thereby significantly expand its business offerings. For the
Sensile Medical business, this will open up new opportunities and
synergies with existing and potential new customers. The combination of
the two companies will also enable Gerresheimer to enhance its Drug
Delivery offering for its Pharmaceutical and Biotech partners,
especially with new digital and electronic capabilities.

As part of Gerresheimer, Sensile Medical is an integral part of this
internationally focused company, with its strong orientation within Drug
and Healthcare sectors in key markets around the world. The broad
offering of products and solutions by Gerresheimer will create a range
of synergies. Gerresheimer’s extensive range of primary packaging for
parenterals will prove valuable in the development of device and
delivery systems. Synergies with Gerresheimer’s production and
commercial manufacturing capabilities, especially in the Medical Plastic
Systems business unit, will allow us to provide complete solutions for
our Partners in the future.

Going forward, it is planned that Sensile Medical will function as the
Development Center for Value Added Devices within the Gerresheimer Group.

Andreas Schütte, Executive Board Member, Gerresheimer AG Plastics &
Devices: “We will accelerate our growth and open new opportunities for
business expansion. Sensile Medical is a perfect fit for us with its
innovative products and platforms in drug delivery systems, including
‘connected’ devices.”

Derek Brandt, Sensile Medical CEO adds: “This transaction represents a
key Milestone in Sensile Medical’s growth strategy. Gerresheimer is an
ideal partner for Sensile Medical in so many ways. We look forward to
becoming part of Gerresheimer’s success in the future.”

About Sensile Medical

Sensile Medical is a globally leading Swiss medical technology company
in the field of Large Volume Injectors. In close corporation with pharma
and biotech companies, we develop devices for liquid drug delivery. The
core of our system is the patented SenseCore technology. The micro pump
is cost-efficient to produce and very accurate in dosage. Our aim is, to
build bridges from drugs to patients. Therefore, our designs are
characterized by modularity and flexibility to meet the patient’s needs
in the best possible way. Sensile Medical employs about 120 employees at
the headquarter in Olten. For more information, visit our website www.sensile-medical.com
or our profile on LinkedIn.

About Gerresheimer

Gerresheimer is a leading global partner to the pharma and healthcare
industries. The company’s special glass and plastic products contribute
to health and well-being. Gerresheimer is a global organization with
about 10,000 employees and manufacturing operations in the local
markets, close to customers. With plants in Europe, North and South
America and Asia Gerresheimer generates revenues of approximately EUR
1.4 billion. The comprehensive product portfolio includes pharmaceutical
packaging products as well as convenient and safe drug delivery systems
such as insulin pens, inhalers, pre-fillable syringes, vials, ampoules,
bottles and containers for liquid and solid pharmaceuticals with closure
and safety systems, plus cosmetic packaging products.

View source version on businesswire.com: https://www.businesswire.com/news/home/20180712005421/en/

Leave a Comment